Irene Flynn-Lombardi
Psychiatric/Mental Health · Vernon, CTNPI 1851977573
Payments from drug & device makers
Across 140 payments — averaging $25.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$986
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$876
- Axsome Therapeutics, Inc.$750
- Vanda Pharmaceuticals Inc.$315
- Otsuka America Pharmaceutical, Inc.$152
- Alkermes, Inc.$147
- plus $325 from 12 others
What the payments were for
- Food & beverage$3,52899%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $986 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $876 |
| Axsome Therapeutics, Inc. | 14 | $750 |
| Vanda Pharmaceuticals Inc. | 18 | $315 |
| Otsuka America Pharmaceutical, Inc. | 8 | $152 |
| Alkermes, Inc. | 7 | $147 |
| Lundbeck LLC | 5 | $91 |
| Johnson & Johnson | 2 | $38 |
| Optinose US, Inc. | 1 | $24 |
| Corium, LLC | 1 | $23 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| TMS Neurohealth Centers Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| GSK | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,551 in reported general payments places this provider in the 90th percentile of 679 psychiatric/mental health providers in Connecticut.
See all psychiatric/mental health providers in Connecticut →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylphenidate Hcl | 25 | $1,291 |
| Sertraline Hcl | 22 | $513 |
| Bupropion XlBupropion Hcl | 12 | $119 |
| Alprazolam | 28 | $98 |
| Trazodone Hcl | 13 | $68 |
| Risperidone | 11 | $63 |
| Buspirone Hcl | 39 | $39 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Vernon
- Cristina MeehanNew Britain$224K
- Samantha MrazBridgeport$87K
- Philip FrickManchester$31K
- Gia SantoroWest Haven$25K
- Donna DraperDanbury$19K
- Zahida SairitupaDanbury$19K
- Hui HuNorwich$19K
- Patrick GagnonMilford$15K
- Max Greger-MoserNew Haven$15K
- Richard ComshawRocky Hill$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.